# Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-2)

> **NCT05481801** · — · COMPLETED · sponsor: **Castilla-La Mancha Health Service** · enrollment: 300 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **BIOLOGICAL:** Covid-19 vaccination
- **BIOLOGICAL:** Influenza vaccination
- **BIOLOGICAL:** Pneumococal vaccination
- **BIOLOGICAL:** Hepatitis B Virus (HBV) vaccination

## Key facts

- **NCT ID:** NCT05481801
- **Lead sponsor:** Castilla-La Mancha Health Service
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2023-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05481801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05481801, "Adherence to Guidelines VAccination in Type 1 DIabetes Mellitus Patients (AVADI-2)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05481801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*